From: Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice
Groups | Challenge with APP1 | Challenge with APP2 | ||||
---|---|---|---|---|---|---|
 | Survival | Lung lesion | Survival | Lung lesion | ||
Control | 0/10 | Severeb | 0/10 | Severeb | ||
Group I | 9/10 | Slighta | Severeb | 9/10 | Slighta | Severeb |
Group II | 5/10 | Moderatea | Severeb | 6/10 | Moderatea | Severeb |
Group III | 6/10 | Moderatea | Severeb | 7/10 | Moderatea | Severeb |